{"id":"https://openalex.org/W2772500522","doi":"https://doi.org/10.4172/2167-065x.1000180","title":"Study of in vitro Therapeutic Equivalence of the 5 mg Glibenclamide Multi-source Tablets Respecting the Reference Medicine Product","display_name":"Study of in vitro Therapeutic Equivalence of the 5 mg Glibenclamide Multi-source Tablets Respecting the Reference Medicine Product","publication_year":2017,"publication_date":"2017-01-01","ids":{"openalex":"https://openalex.org/W2772500522","doi":"https://doi.org/10.4172/2167-065x.1000180","mag":"2772500522"},"language":"en","primary_location":{"id":"doi:10.4172/2167-065x.1000180","doi":"https://doi.org/10.4172/2167-065x.1000180","is_oa":true,"landing_page_url":"https://doi.org/10.4172/2167-065x.1000180","pdf_url":null,"source":{"id":"https://openalex.org/S2764807964","display_name":"Clinical Pharmacology & Biopharmaceutics","issn_l":"2167-065X","issn":["2167-065X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320466","host_organization_name":"OMICS Publishing Group","host_organization_lineage":["https://openalex.org/P4310320466"],"host_organization_lineage_names":["OMICS Publishing Group"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Biopharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.4172/2167-065x.1000180","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054979533","display_name":"\u00c1ngel Alvarado Yarasca","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angel Alvarado Yarasca","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Ana Maria Munoz Jauregui","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ana Maria Munoz Jauregui","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111380992","display_name":"Luis Qui\u00f1ones Sep\u00falveda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luis Quinones Sepulveda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033557304","display_name":"Frank Lizaraso-Soto","orcid":"https://orcid.org/0000-0001-9993-9998","observed_orcids":["https://orcid.org/0000-0001-9993-9998"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frank Lizaraso Soto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065581191","display_name":"Alberto Salazar\u2010Granara","orcid":"https://orcid.org/0000-0003-1996-3176","observed_orcids":["https://orcid.org/0000-0003-1996-3176"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alberto Salazar Granara","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061280138","display_name":"Luis Sull\u00f3n-Dextre","orcid":"https://orcid.org/0000-0001-6282-963X","observed_orcids":["https://orcid.org/0000-0001-6282-963X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luis Sullon Dextre","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009381707","display_name":"Juan J. Palomino-Jhong","orcid":"https://orcid.org/0000-0001-9944-6261","observed_orcids":["https://orcid.org/0000-0001-9944-6261"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juan Jose Palomino Jhong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5053344198","display_name":"Jorge A. Garc\u00eda","orcid":"https://orcid.org/0000-0001-9880-7344","observed_orcids":["https://orcid.org/0000-0001-9880-7344"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jorge Antonio Garcia Ceccarelli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"06","issue":"04","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.7675999999046326,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.7675999999046326,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","score":0.12229999899864197,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.033799998462200165,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glibenclamide","display_name":"glibenclamide","score":0.9760000109672546},{"id":"https://openalex.org/keywords/therapeutic-equivalence","display_name":"therapeutic equivalence","score":0.9319999814033508},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.9010000228881836},{"id":"https://openalex.org/keywords/in-vitro-dissolution","display_name":"in vitro dissolution","score":0.6970000267028809},{"id":"https://openalex.org/keywords/reference-drugs","display_name":"reference drugs","score":0.5529999732971191},{"id":"https://openalex.org/keywords/similarity-factor-f2","display_name":"similarity factor f2","score":0.906000018119812},{"id":"https://openalex.org/keywords/dissolution-media-ph","display_name":"dissolution media pH","score":0.6000000238418579},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.7739999890327454}],"concepts":[{"id":"https://openalex.org/C2779768347","wikidata":"https://www.wikidata.org/wiki/Q420626","display_name":"Glibenclamide","level":3,"score":0.8151094913482666},{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.7800485491752625},{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.6481823921203613},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6183551549911499},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.4842941164970398},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4770768880844116},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.46408817172050476},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4237959086894989},{"id":"https://openalex.org/C2780069185","wikidata":"https://www.wikidata.org/wiki/Q7977945","display_name":"Equivalence (formal languages)","level":2,"score":0.41842466592788696},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41123485565185547},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.3613557517528534},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.21508097648620605},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13806092739105225},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.10004323720932007},{"id":"https://openalex.org/C118615104","wikidata":"https://www.wikidata.org/wiki/Q121416","display_name":"Discrete mathematics","level":1,"score":0.0},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.0},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.4172/2167-065x.1000180","doi":"https://doi.org/10.4172/2167-065x.1000180","is_oa":true,"landing_page_url":"https://doi.org/10.4172/2167-065x.1000180","pdf_url":null,"source":{"id":"https://openalex.org/S2764807964","display_name":"Clinical Pharmacology & Biopharmaceutics","issn_l":"2167-065X","issn":["2167-065X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320466","host_organization_name":"OMICS Publishing Group","host_organization_lineage":["https://openalex.org/P4310320466"],"host_organization_lineage_names":["OMICS Publishing Group"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Biopharmaceutics","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.4172/2167-065x.1000180","doi":"https://doi.org/10.4172/2167-065x.1000180","is_oa":true,"landing_page_url":"https://doi.org/10.4172/2167-065x.1000180","pdf_url":null,"source":{"id":"https://openalex.org/S2764807964","display_name":"Clinical Pharmacology & Biopharmaceutics","issn_l":"2167-065X","issn":["2167-065X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320466","host_organization_name":"OMICS Publishing Group","host_organization_lineage":["https://openalex.org/P4310320466"],"host_organization_lineage_names":["OMICS Publishing Group"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Biopharmaceutics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4288363541","https://openalex.org/W2884743720","https://openalex.org/W4392397560","https://openalex.org/W4404790089","https://openalex.org/W3111202963","https://openalex.org/W2716776056","https://openalex.org/W7220802266","https://openalex.org/W4408822037","https://openalex.org/W4214819758","https://openalex.org/W2069862547"],"abstract_inverted_index":{"Introduction:":[0],"Therapeutic":[1],"equivalence":[2,25],"of":[3,26,63,86,165,194,206],"medications":[4],"is":[5,197,210],"carried":[6],"out":[7],"through":[8],"in":[9,12,22,55,60,166,213],"vitro":[10,23,167,214],"and":[11,38,47,57,68,107,127,130,159,179,191],"vivo":[13],"studies":[14],"called":[15],"bioequivalence":[16],"studies.":[17],"Objective:":[18],"To":[19],"determine":[20],"the":[21,27,34,41,48,87,93,98,141,146,187,192,200,207,216],"therapeutic":[24],"5":[28,44,50,203,218],"mg":[29,45,51,204,219],"glibenclamide":[30,46,205],"multi-source":[31,42,94],"tablets":[32],"respecting":[33],"reference":[35,49,99,217],"medicine.":[36],"Materials":[37],"methods:":[39],"Both,":[40],"drug":[43,95,202],"Glidiabet":[52],"are":[53],"made":[54],"Peru,":[56],"were":[58,73],"acquired":[59],"a":[61],"drugstore":[62],"Ica":[64],"city":[65],"(Peru).":[66],"Reagents":[67],"an":[69],"analytical":[70],"grade":[71],"standard":[72],"used.":[74],"The":[75,135,163],"Ultraviolet":[76],"absorption":[77],"method":[78],"at":[79,104,108,117],"300":[80],"nm":[81],"was":[82,139,152,170],"used":[83],"on":[84],"each":[85],"three":[88,147],"dissolution":[89,120,168],"media.":[90],"Results:":[91],"Neither":[92],"T":[96],"nor":[97],"R":[100],"dissolved":[101],"by":[102],"85%":[103],"pH":[105,109,118],"1.2":[106],"4.5,":[110],"during":[111],"15":[112],"or":[113],"30":[114],"minutes.":[115],"However,":[116],"6.8":[119],"occurs.":[121],"These":[122],"results":[123],"correspond":[124],"to":[125,186,215],"Food":[126],"Drug":[128],"Administration":[129],"United":[131],"States":[132],"Pharmacopoeia":[133],"criteria.":[134],"similarity":[136,188],"factor":[137,189],"value":[138],"within":[140],"acceptance":[142],"range":[143],"(50-100)":[144],"for":[145],"tested":[148],"pHs.":[149],"Dissolution":[150],"efficiency":[151,193],"68.66%":[153],"(pH":[154,157,161,173,177,182],"1.2),":[155,174],"56.59%":[156],"4.5)":[158,178],"95.98%":[160],"6.8).":[162,183],"mean":[164],"time":[169],"28.56":[171],"min":[172,176,181],"39.97":[175],"4.54":[180],"Conclusion:":[184],"According":[185],"(f2)":[190],"dissolution,":[195],"it":[196],"concluded":[198],"that":[199],"multisource":[201],"present":[208],"study":[209],"therapeutically":[211],"equivalent":[212],"Glidiabet.":[220]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2017-12-22T00:00:00"}